Daniel Bouthillier

Daniel Bouthillier

Chief Tech/Sci/R&D Officer at DEVONIAN HEALTH GROUP INC.

Health Technology
Commercial Services
Consumer Services

Profile

Daniel Bouthillier was the founder of Kaneq Bioscience Ltd.
(founded in 2012) where he held the title of President & Chief Executive Officer.
He is also the founder of Kaneq Pharma, Inc. Dr. Bouthillier's current jobs include Director positions at Québec Biotechnology Innovation Centre, Kanyr Pharma, Inc., and Vice President-Research at Devonian Health Group, Inc. His former jobs include Vice Chairman at Génome Québec, Inc., Executive Director-Global Facilities Management at Merck & Co., Inc. (from 2007 to 2010), and Senior Scientist & Head-Administrator at Clinical Research Institute of Montreal.
Dr. Bouthillier received a doctorate from the University of Montréal and an MBA from HEC Montréal.

Daniel Bouthillier active positions

CompaniesPositionStart
DEVONIAN HEALTH GROUP INC. Chief Tech/Sci/R&D Officer -
Director/Board Member -
Kanyr Pharma, Inc. Director/Board Member -
All active positions of Daniel Bouthillier

Former positions of Daniel Bouthillier

CompaniesPositionEnd
MERCK & CO., INC. Corporate Officer/Principal 2010-07-31
Chief Administrative Officer -
Director/Board Member -
Kaneq Pharma, Inc. Founder -
Chief Executive Officer -
See the detail of Daniel Bouthillier's experience

Training of Daniel Bouthillier

University of Montréal Doctorate Degree
HEC Montréal Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Bouthillier's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
DEVONIAN HEALTH GROUP INC.

Health Technology

MERCK & CO., INC.

Health Technology

Private companies6

Health Technology

Commercial Services

Health Technology

Kaneq Pharma, Inc.

Commercial Services

Kanyr Pharma, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Daniel Bouthillier
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW